JPY 2953.0
(-0.03%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 16.41 Billion JPY | -47.94% |
2022 | 30.57 Billion JPY | -46.45% |
2021 | 56.25 Billion JPY | 117.18% |
2020 | 26.49 Billion JPY | 71.37% |
2019 | 15.34 Billion JPY | -5.5% |
2018 | 16.21 Billion JPY | 7.06% |
2017 | 15.14 Billion JPY | 1.35% |
2016 | 14.71 Billion JPY | 1.86% |
2015 | 14.61 Billion JPY | 8.51% |
2014 | 13.21 Billion JPY | -4.55% |
2013 | 14.12 Billion JPY | 10.5% |
2012 | 12.77 Billion JPY | 14.68% |
2011 | 11.69 Billion JPY | -2.75% |
2010 | 11.29 Billion JPY | 1.24% |
2009 | 11.11 Billion JPY | 13.76% |
2008 | 9.76 Billion JPY | 23.22% |
2007 | 7.74 Billion JPY | 9.86% |
2006 | 8.08 Billion JPY | -10.87% |
2005 | 8.02 Billion JPY | 8.11% |
2004 | 7.6 Billion JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 4.19 Billion JPY | 26.81% |
2023 Q3 | 2.83 Billion JPY | 12.45% |
2023 Q4 | 3.18 Billion JPY | 12.23% |
2023 FY | - JPY | -47.94% |
2023 Q2 | 2.52 Billion JPY | -9.11% |
2023 Q1 | 2.77 Billion JPY | -30.22% |
2022 Q3 | 4.99 Billion JPY | -41.91% |
2022 Q2 | 8.6 Billion JPY | 29.63% |
2022 Q1 | 6.63 Billion JPY | -53.56% |
2022 FY | - JPY | -46.45% |
2022 Q4 | 3.97 Billion JPY | -20.42% |
2021 Q4 | 14.29 Billion JPY | 70.89% |
2021 FY | - JPY | 117.18% |
2021 Q1 | 14.87 Billion JPY | 95.88% |
2021 Q2 | 13.57 Billion JPY | -8.79% |
2021 Q3 | 8.36 Billion JPY | -38.35% |
2020 Q4 | 7.59 Billion JPY | -4.46% |
2020 FY | - JPY | 71.37% |
2020 Q2 | 5.26 Billion JPY | 19407.41% |
2020 Q3 | 7.95 Billion JPY | 50.96% |
2020 Q1 | 27 Million JPY | -97.27% |
2019 Q1 | 3.34 Billion JPY | 92.73% |
2019 FY | - JPY | -5.5% |
2019 Q4 | 988 Million JPY | -65.05% |
2019 Q3 | 2.82 Billion JPY | -8.63% |
2019 Q2 | 3.09 Billion JPY | -7.37% |
2018 Q2 | 2.65 Billion JPY | -20.25% |
2018 Q3 | 3.14 Billion JPY | 18.52% |
2018 Q4 | 1.73 Billion JPY | -44.84% |
2018 FY | - JPY | 7.06% |
2018 Q1 | 3.32 Billion JPY | 132.61% |
2017 Q3 | 2.46 Billion JPY | -15.91% |
2017 FY | - JPY | 1.35% |
2017 Q2 | 2.93 Billion JPY | -0.58% |
2017 Q1 | 2.95 Billion JPY | 97.59% |
2017 Q4 | 1.42 Billion JPY | -42.1% |
2016 Q3 | 2.46 Billion JPY | -8.69% |
2016 Q1 | 3.08 Billion JPY | 84.46% |
2016 Q2 | 2.7 Billion JPY | -12.38% |
2016 Q4 | 1.49 Billion JPY | -39.49% |
2016 FY | - JPY | 1.86% |
2015 Q3 | 2.58 Billion JPY | 12.71% |
2015 Q4 | 1.67 Billion JPY | -35.18% |
2015 FY | - JPY | 8.51% |
2015 Q1 | 2.33 Billion JPY | 163.32% |
2015 Q2 | 2.29 Billion JPY | -1.84% |
2014 Q2 | 2 Billion JPY | -16.14% |
2014 Q1 | 2.39 Billion JPY | 123.25% |
2014 FY | - JPY | -4.55% |
2014 Q4 | 886 Million JPY | -60.29% |
2014 Q3 | 2.23 Billion JPY | 11.27% |
2013 Q1 | 2.73 Billion JPY | 161.13% |
2013 Q2 | 2.4 Billion JPY | -12.11% |
2013 Q4 | 1.07 Billion JPY | -56.05% |
2013 FY | - JPY | 10.5% |
2013 Q3 | 2.43 Billion JPY | 1.41% |
2012 Q4 | 1.04 Billion JPY | -51.05% |
2012 FY | - JPY | 14.68% |
2012 Q3 | 2.13 Billion JPY | 9.02% |
2012 Q2 | 1.96 Billion JPY | 2.51% |
2012 Q1 | 1.91 Billion JPY | 297.92% |
2011 Q2 | 1.62 Billion JPY | 5.19% |
2011 FY | - JPY | -2.75% |
2011 Q4 | 481 Million JPY | -71.27% |
2011 Q3 | 1.67 Billion JPY | 3.21% |
2011 Q1 | 1.54 Billion JPY | -16.33% |
2010 Q1 | 3.47 Billion JPY | 52.78% |
2010 FY | - JPY | 1.24% |
2010 Q4 | 1.84 Billion JPY | -39.28% |
2010 Q3 | 3.03 Billion JPY | -2.44% |
2010 Q2 | 3.11 Billion JPY | -10.37% |
2009 Q3 | 2.75 Billion JPY | -11.8% |
2009 Q2 | 3.12 Billion JPY | -1.05% |
2009 Q1 | 3.16 Billion JPY | 43.59% |
2009 FY | - JPY | 13.76% |
2009 Q4 | 2.27 Billion JPY | -17.68% |
2008 Q4 | 2.2 Billion JPY | -16.18% |
2008 FY | - JPY | 23.22% |
2008 Q2 | 1.55 Billion JPY | 0.0% |
2008 Q3 | 2.62 Billion JPY | 69.46% |
2007 FY | - JPY | 9.86% |
2006 FY | - JPY | -10.87% |
2005 FY | - JPY | 8.11% |
2004 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Shin Nippon Biomedical Laboratories, Ltd. | 8.98 Billion JPY | -82.815% |
DNA Chip Research Inc. | -217 Million JPY | 7666.359% |
Cosmo Bio Company,Limited | 669 Million JPY | -2354.26% |
H.U. Group Holdings, Inc. | 13.64 Billion JPY | -20.312% |
FALCO HOLDINGS Co., Ltd. | 3.13 Billion JPY | -424.234% |
Human Metabolome Technologies, Inc. | 306.48 Million JPY | -5257.213% |
Precision System Science Co., Ltd. | -661.75 Million JPY | 2581.148% |